Anaplastic lymphoma kinase (ALK) as an oncogene capable of transforming normal human cells

• 1. 一种正常人NCM460细胞恶性转化模型的建立方法及鉴定方法 [P] . 中国专利： CN105907702A . 2016-08-31
• 2. 一种靶向人非小细胞肺癌细胞株中EML4-ALK融合基因变体1的载体及应用 [P] . 中国专利： CN114107384A . 2022-03-01
• 3. Anaplastic Lymphoma Kinase (ALK) As An Oncogene Capable Of Transforming Normal Human Cells [P] . 美国专利： US2016194616A1 . 2016-07-07

  机译： 间变性淋巴瘤激酶（ALK）作为能够转化正常人细胞的致癌基因

• 4. Anaplastic Lymphoma Kinase (ALK) As An Oncogene Capable Of Transforming Normal Human Cells [P] . 美国专利： US2015031856A1 . 2015-01-29

  机译： 间变性淋巴瘤激酶（ALK）作为能够转化正常人细胞的致癌基因

• 5. METHOD OF IDENTIFYING TREATMENT RESPONSIVE NON-SMALL CELL LUNG CANCER USING ANAPLASTIC LYMPHOMA KINASE (ALK) AS A MARKER [P] . 美国专利： US2020225237A1 . 2020-07-16

  机译： 以再生性淋巴激酶（ALK）为标记物识别治疗反应性非小细胞肺癌的方法

• 1. Relationship between molecular changes in epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) mutations in lung adenocarcinoma [J] . Rina Na, Wei Luan, Yinzai He, 中德临床肿瘤学杂志（英文版） . 2021,第004期
• 2. Relationship between molecular changes in epidermal growth factor receptor(EGFR)and anaplastic lymphoma kinase(ALK)mutations in lung adenocarcinoma [J] . Rina Na, Wei Luan, Yinzai He, 肿瘤学与转化医学（英文） . 2021,第004期
• 3. IGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK+ anaplastic large-cell lymphoma cells. [J] . Shi P, Lai R, Lin Q Blood: The Journal of the American Society of Hematology . 2009,第2期
• 4. Analysis of nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-reactive CD8(+) T cell responses in children with NPM-ALK(+) anaplastic large cell lymphoma [J] . Singh V. K., Werner S., Hackstein H., Clinical and Experimental Immunology: An Official Journal of the British Society for Immunology . 2016,第1期
• 5. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC- and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene [J] . Jo-Anne van der Krogt, Marlies Vanden Bempt, Julio Finalet Ferreiro, Haematologica . 2017,第9期
• 6. Effects of ELF on c-myc oncogene expression in normal and transformed human cells [C] . Czerska, E., Casamento, . 1992
• 7. Understanding the function of the JunB transcription factor in anaplastic lymphoma kinase-positive, anaplastic large cell lymphoma. [D] . Pearson, Joel Dylan. 2013
• 8. Lymphoid Neoplasia: IGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK+ anaplastic large-cell lymphoma cells [O] . Ping Shi, Raymond Lai, Quan Lin, -1
• 9. IGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK+ anaplastic large-cell lymphoma cells [O] . Shi, Ping, Lai, Raymond, Lin, Quan, 2009

• 1. Primary bone anaplastic lymphoma kinase positive anaplastic largecell lymphoma: A case report and review of the literature [J] . Wei Zheng ,Qiao-Qiao Yin ,Tian-Chen Hui . 世界临床病例杂志 . 2021,第014期
• 2. Acute leukemic phase of anaplastic lymphoma kinase-anaplastic large cell lymphoma: A case report and review of the literature [J] . Huai-Feng Zhang ,Yan Guo . 世界临床病例杂志 . 2020,第021期
• 3. Anaplastic lymphoma kinase-negative anaplastic large cell lymphoma masquerading as Behcet''''s disease:A case report and review of literature [J] . Juan Luo ,Ying-Han Jiang ,Zi Lei . 世界临床病例杂志 . 2019,第020期
• 4. 细胞信号转号、基因表达、DNA复制保真度与哺乳细胞非定标性突变－－致癌物诱发基因突变分子机制研究 [C] . 余应年 ,孙雪敏 ,冯朝晖 . 中国病理生理学会第七届年会，第九届心血管，第六届国际心脏，第七届肿瘤，第八届免疫，第六届受体和信号，第三届消化学术研讨会 . 2000
• 5. 应用Affymetrix全基因组表达谱芯片研究正常人上皮细胞对化学致癌物BPDE的应答反应 [A] . 卢翔云 . 2009